Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly

Manuscript Number: 

15-1155R1

Author(s): 
Nicholas J. Ashton, Alison L. Baird, David Baker, Chantal Bazenet, Cristina Cereda, John Graf, Cristina Tan Hehir, Abdul Hye, Mizanur Khondoker, Steven J. Kiddle, Emanuela Leoni, Rufina Leung, Simon Lovestone, Steven Lynham, Ricardo Sainz-Fuertes, Madhav Thambisetty, Malcolm A. Ward, Sarah Westwood

Disclosures

Nicholas J. Ashton

  • Nothing to Disclose

Alison L. Baird

  • Nothing to Disclose

David Baker

  • Nothing to Disclose

Chantal Bazenet

  • Nothing to Disclose

Cristina Cereda

  • Nothing to Disclose

John Graf

  • Equity:
    GE stock options but minor extent.
    Sponsors:
    GE Healthcare funded part of the study. I work for GE Global Research as part of the General Electric Corporation.
    Patents/Royalties
    I work for GE Global Research and have been an inventor on approximately 25 issued US patents owned by GE.

Cristina Tan Hehir

  • Equity:
    Stock options at General Electric
    Sponsors:
    Employee of General Electric

Abdul Hye

  • Nothing to Disclose

Mizanur Khondoker

  • Nothing to Disclose

Steven J. Kiddle

  • Nothing to Disclose

Emanuela Leoni

  • Nothing to Disclose

Rufina Leung

  • Nothing to Disclose

Simon Lovestone

  • Consulting Fees:
    No consultancy for more than three years. In the last five years, consultancy for Merck and NICE,
    Lecture Fees:
    Occasional speaker fees for lectures at the Lundbeck Neuroscience Institute
    Patents/Royalties
    Patents pertaining to Alzheimer's held by KCL and Proteome Sciences
    Grants
    • Agency: 
      EU and EFPIA companies
      Dates: 
      2013-2020

Steven Lynham

  • Nothing to Disclose

Ricardo Sainz-Fuertes

  • Nothing to Disclose

Madhav Thambisetty

  • Nothing to Disclose

Malcolm A. Ward

  • Equity:
    I hold stock options granted by Proteome Sciences plc

Sarah Westwood

  • Nothing to Disclose